Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
TUKYSA™ (tucatinib) for the treatment of HER2-Positive Breast Cancer
Tucatinib is an inhibitor of HER2 tyrosine kinase. Credit: Business Wire
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Jeeva Informatics Solutions
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a...
About
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a mission to develop artificial intelligence (AI)-driven decentralised clinical trials and optimise patient-focused clinical research.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Cellular Technology Limited
Cellular Technology Limited (CTL) is a global biotechnology company specialized...
About
Cellular Technology Limited (CTL) is a global biotechnology company specialized in the development, use, and manufacture of standardized tools for cellular immune assays.
FollowMake an Enquiry